Journal

In clinical AI, free access is no longer a gimmick. It is a distribution strategy, a habit-formation engine, and increasingly a defensible wedge. The products that win early mindsh...

Doctors and medical students often assume the best tool for a quick clinical answer should also be the best tool for retention and revision. Usually it is not. Understanding and re...

AMBOSS is no longer positioning itself as only a question bank. With AI Mode for clinical care, AI Mode Learning, and a redesigned interface spanning Learning, Clinical Care, and T...

A practical guide to AI tools for UK doctors in 2026, covering iatroX, Standard Medicine, AMBOSS, clinical reference, ambient documentation and professional learning.

AI is starting to change CPD from a separate admin task into something captured from real clinical work. For UK clinicians, the key question is not whether a tool can log activity,...

Umbil is one of the more interesting UK-facing clinical AI tools because it sits between guideline retrieval, workflow drafting, and CPD capture. For UK clinicians, the real questi...

Clinical AI may create value by anticipating the next appropriate task, but downstream automation needs context, permissions, review and completion evidence.

Summarisation is still useful, but it is becoming easier to imitate and harder to defend on its own. In 2026, the higher-value layer of healthcare AI is moving toward anticipation:...

Healthcare AI agents are moving through scheduling, follow-up and bounded clinical pathways. Compare whose authority they use, what they complete and how exceptions are handled.

Clinical AI is moving closer to records and actions, while standalone tools must demonstrate specialisation, useful independence and a reason to leave the workflow.

Clinical AI is moving into a new phase. Search was phase one. Workflow placement is phase two. In 2026, the most important question is no longer just which product has the best ans...

Pathway now points users to Doximity Ask. Check current product naming, US account eligibility and alternatives for clinical reference and learning.